Tokyo Tape
Sign in
← MedPeer

Quarterly report · Q2

6095.TEDINET S100QPSY
Period2022-10-01 → 2023-03-31
Filed2023-05-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥7.1bn2022-10-01 → 2023-03-31Cons.Net sales
Revenue¥8.5bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥4.4bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥717m2022-10-01 → 2023-03-31Cons.Operating income
Operating income¥867m2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥735m2022-10-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥1.1bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥735m2022-10-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥890m2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥380m2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥812m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥599m2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥391m2022-10-01 → 2023-03-31Cons.Profit loss
Net income¥618m2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥14.5bnat 2023-03-31Cons.Assets
Total assets¥9.4bnat 2022-09-30Cons.Assets
Total assets¥9.2bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2023-03-31Cons.Liabilities
Total liabilities¥1.5bnat 2022-09-30Cons.Liabilities
Net assets / equity¥8.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥7.6bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥5.7bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥5.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.7bnat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow¥122m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥853m2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥538m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.8bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥423m2021-10-01 → 2022-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥4.2bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥7m2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥21m2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥17.422022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.622021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.742021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.572022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥17.052022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.782021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.262021-10-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio57.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio79.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥5m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥657m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥5.7bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥243m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥240m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2023-03-31−¥40m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2023-03-31¥1.2bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥300,000
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2023-03-31¥94m
—segment totalrevenue2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥7.1bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥5m
—segment totalsegment profit2022-10-01 → 2023-03-31¥1.4bn
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-03-31−¥7m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-03-31−¥645m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥3.2bn
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥2m
jpcrp040300-q2r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥1.3bn
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥202m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥199m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥30m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2021-10-01 → 2022-03-31¥1.0bn
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥3m
jpcrp040300-q2r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2021-10-01 → 2022-03-31¥137m
—segment totalrevenue2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥4.4bn
—segment totalrevenue intersegment2021-10-01 → 2022-03-31¥7m
—segment totalsegment profit2021-10-01 → 2022-03-31¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 506
ItemContextValueUnit
Amortization of goodwill sgaCurrentYTDDuration283721000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember3201974000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember199127000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember1039377000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember4440479000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration4440479000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember2086000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember2708000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember2645000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember7440000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-7440000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember3204061000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember201835000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember1042022000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember4447919000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-7440000JPY
Net salesPrior1YTDDuration4440479000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember1344804000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember30064000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember137354000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember1512223000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-645364000JPY
Operating incomePrior1YTDDuration866859000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember5709916000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember240426000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember1178698000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember7129040000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration7129040000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember1795000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember2566000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember300000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember4661000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-4661000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember5711711000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember242992000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember1178998000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember7133702000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-4661000JPY
Net salesCurrentYTDDuration7129040000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000CollectiveIntelligencePlatformReportableSegmentMember1320599000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000MedicalInstitutionSupportPlatformReportableSegmentMember-40191000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E30650-000PreventiveHealthcarePlatformReportableSegmentMember93698000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember1374107000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-657139000JPY
Operating incomeCurrentYTDDuration716967000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass